Overview
The study was initiated by NICHD’s Pregnancy and Perinatology Branch and was primarily funded by NICHD, with co-funding from the NIH Office of Research on Women’s Health. A National Heart, Lung, and Blood Institute-funded substudy of 3,600 nuMoM2b participants examined the relationship between sleep disorders during pregnancy and adverse pregnancy outcomes.
nuMoM2b enrolled racially, ethnically, and geographically diverse pregnant women through 8 clinical research sites and 12 subsites around the country. These women participated in a variety of tests to identify potential mechanisms of adverse outcomes and predictive factors for the outcomes at four points during pregnancy.
Researchers collected additional data through ancillary studies on subsets of the enrolled women.
Topic Areas
nuMoM2b studied the mechanisms and prediction of adverse outcomes in pregnancy. The primary outcomes of interest were preterm birth, preeclampsia, fetal growth restriction, and stillbirth. The study aimed to:
- Determine maternal characteristics and biomarkers, including genetics, epigenetics, and physiological response to pregnancy, as well as the environmental factors that can influence or predict adverse pregnancy outcomes
- Identify specific aspects of placental development and function that lead to adverse pregnancy outcomes
- Characterize genetic, growth, and developmental parameters of the fetus associated with adverse pregnancy outcomes
Network Sites
- Case Western Reserve University
- Columbia University
- Indiana University
- Northwestern University
- Magee-Women’s Hospital
- RTI International (data coordinating and analysis center)
- University of California, Irvine
- University of Pennsylvania
- University of Utah
In addition, 12 subsites participated in nuMoM2b.
More Information
- Decoding Maternal Morbidity Data Challenge: https://www.nichd.nih.gov/research/supported/challenges/decoding-maternal-morbidity
- ClinicalTrials.gov: nuMoM2b Page
- PubMed articles on nuMoM2b study
- NICHD Contact: Monica Longo